Links to 2 New Articles on HCV at HIVandHepatitis.com

[Guest guest]

Telaprevir plus Standard Therapy Can Produce Hepatitis C

Cure in Less TimeAdding the

hepatitis C virus (HCV) protease inhibitor telaprevir

(Incivek) to pegylated interferon plus ribavirin increases

the chances of sustained response and many patients achieved

a cure with a shorter course of therapy, researchers reported

in the September 15, 2011, New England Journal of Medicine.Discovery

May Aid Development of Hepatitis C VaccineAustralian

researchers have shed new light on the natural history

of hepatitis C virus (HCV) by performing a longitudinal

genetic analysis of the virus in 4 patients from the first

few weeks after infection until resolution (spontaneous

clearance or establishment of chronic infection).

[Guest guest]

Telaprevir plus Standard Therapy Can Produce Hepatitis C

Cure in Less TimeAdding the

hepatitis C virus (HCV) protease inhibitor telaprevir

(Incivek) to pegylated interferon plus ribavirin increases

the chances of sustained response and many patients achieved

a cure with a shorter course of therapy, researchers reported

in the September 15, 2011, New England Journal of Medicine.Discovery

May Aid Development of Hepatitis C VaccineAustralian

researchers have shed new light on the natural history

of hepatitis C virus (HCV) by performing a longitudinal

genetic analysis of the virus in 4 patients from the first

few weeks after infection until resolution (spontaneous

clearance or establishment of chronic infection).